Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup Analyses.

Journal of the American College of Cardiology·2026
Same author

Sex differences in the prognosis of nonsustained ventricular tachycardia detected on Holter recording.

Heart rhythm O2·2025
Same author

The Association Between Chronic Kidney Disease and Third-Degree Atrioventricular Block: A Danish Nationwide Study.

JACC. Clinical electrophysiology·2024
Same author

Risk factors associated with clinically relevant pericardial effusion after primary cardiac implantable electronic device implantation.

Journal of cardiovascular electrophysiology·2024
Same author

Treated periodontitis and recurrent events after first-time myocardial infarction: A Danish nationwide cohort study.

Journal of clinical periodontology·2023
Same author

The effect of discontinuing beta-blockers after different treatment durations following acute myocardial infarction in optimally treated, stable patients without heart failure: a Danish, nationwide cohort study.

European heart journal. Cardiovascular pharmacotherapy·2023

Related Experiment Video

Updated: May 7, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Atrial fibrillation.

Casper N Bang1

  • 1Department of Cardiology, Rigshospitalet, Blegdamsvej 9, 2100 København Ø, Denmark. casperbang@hotmail.com.

Danish Medical Journal
|October 3, 2013
PubMed
Summary
This summary is machine-generated.

Statins did not prevent new-onset atrial fibrillation (AF) in asymptomatic aortic stenosis (AS) patients. However, statin use showed a preventive effect in myocardial infarction (MI) patients, with good compliance being key.

More Related Videos

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
09:17

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation

Published on: July 29, 2011

Related Experiment Videos

Last Updated: May 7, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
09:17

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation

Published on: July 29, 2011

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Atrial fibrillation (AF) is a common complication post-myocardial infarction (MI) and in aortic stenosis (AS) patients, associated with adverse outcomes.
  • Statins possess anti-inflammatory and antioxidant properties, suggesting a potential role in preventing AF.
  • Existing recommendations support statins for AF prevention post-coronary artery bypass grafting (CABG), but evidence in asymptomatic AS and large MI cohorts is limited.

Purpose of the Study:

  • To investigate the preventive effect of statins on new-onset AF in asymptomatic AS patients.
  • To evaluate the role of statins in preventing new-onset AF in a large cohort of first-time MI patients.
  • To conduct a meta-analysis of existing studies on statin use for AF prevention in non-cardiac surgery patients.

Main Methods:

  • Analysis of a randomized patient sample (n=1,873) from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
  • Utilized a Danish register patient sample (n=97,499) of first-time MI patients.
  • Performed a meta-analysis of published studies up to June 2011 on statin treatment and new-onset/recurrent AF in non-surgical cardiac patients.

Main Results:

  • Statins did not reduce the incidence or time to new-onset AF in asymptomatic AS patients.
  • Statin treatment demonstrated an independent preventive effect on new-onset AF in MI patients, with potential type- and dose-dependent effects.
  • Good compliance to statin therapy was crucial for AF prevention; meta-analysis showed a preventive effect in observational studies but not in randomized controlled trials.

Conclusions:

  • Primary statin treatment is not recommended for preventing new-onset AF in AS patients.
  • While a potential preventive effect exists in MI patients, further research is needed; good compliance is important.
  • The preventive effect of statins on AF in patients not undergoing cardiac surgery remains inconclusive, with differing results between observational and randomized studies.